Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Board Meeting Outcome For Allotment Of 5000 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares

This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done allotment of convertible warrants on preferential basis to Non-promoters on March 22, 2024. Further, we would like to inform that the Warrant Holder have paid the balance of the consideration aggregating to Rs 12,45,250/- and have applied for exercising their rights for conversion of 2,500 warrants into equivalent number of equity Shares.
22-03-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Results- Outcome For The Board Meeting Dated 14.02.2024

Results- Outcome for the Board Meeting dated 14.02.2024
14-02-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome For The Board Meeting Dated 14.02.2024

We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Wednesday, 14 February, 2024 had considered and approved the following item: 1. In compliance to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2023 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 02:00 P.M. and concluded at 07:00 P.M.
14-02-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Board Meeting Of The Company On Wednesday, 14Th February, 2024.

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve To discuss, consider and approve Unaudited Financial Results of the Company for the Quarter and Nine Months ended 31St Decembers, 2023.
05-02-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Outcome of EGM

This is to inform you that the EOGM of Fredun Pharmaceuticals Ltd was held on Thursday, January 18,2024 at 03:00 p.m (IST) through VC/OAVM ,in accordance with the circulars issued by the MCA and SEBI.
18-01-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under regulation 39(3) of SEBI(Listing Obligations and Disclosures Requirements) Regulations, 2015 for loss/misplacement of original Share Cettoificate
17-01-2024
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with REg 74(5) of SEBI (Depositories and participants) reg,2018 we furnish hereunder certificate dated 01.01.2024 recieved from RTA for quarter ended 31.12.2023.
03-01-2024
Next Page
Close

Let's Open Free Demat Account